Target intelligence / Profile preview

MicroRNA 378b (MIR378B)

Target
MIR378B
Molecular classification
microRNA, non-coding RNA
01

Overview

MicroRNA 378b (MIR378B) is a member of the microRNA gene family, short (20–24 nucleotide) non-coding RNAs that modulate gene expression by targeting mRNAs for destabilization or translational inhibition. MIR378B is embedded in the human genome and processed from a stem-loop precursor transcript, ultimately incorporated into RISC complexes to perform its regulatory role. In brown adipose tissue, miR-378b promotes expansion through direct repression of Pde1b, increasing cAMP signaling and fostering metabolic adaptation. In muscle, it coordinates autophagy and apoptosis by targeting PDK1 (autophagy initiation) and Caspase 9 (apoptosis), thereby maintaining muscle homeostasis and preventing muscle wasting. In cancer, miR-378b acts either as an oncogene or a tumor suppressor, modulating cell survival, proliferation, migration, and invasion via suppression of targets like Sufu, Fus-1, ATG12, CCND1, and pRb. Its levels are aberrant in many tumor types and linked to prognosis and disease aggressiveness. Experimental therapeutics focus on its regulation via mimics or inhibitors, with ongoing research into its clinical utility and safety implications.

Other names
hsa-mir-378bmiR-378bMIR378BmicroRNA 378b
02

Mechanism of action

Antisense oligonucleotides/inhibitors bind to MIR378B and block its function, leading to derepression of its target genes (e.g., PDK1, Caspase 9, Sufu, Fus-1, ATG12). miRNA mimics or overexpression can reinforce MIR378B function, suppressing targets and altering cell survival, growth, and apoptosis.

03

Biological functions

Post-transcriptional gene regulationCell survivalApoptosis (inhibition or promotion depending on context)Autophagy regulationCell proliferationCell migration and invasionBrown adipose tissue expansionLipogenesisFatty acid oxidation
04

Disease associations

Cancer (oncogene/tumor suppressor roles in different tumor types; angiogenesis, metastasis, invasion)Muscle dystrophy and myopathiesMetabolic syndromes (adipose tissue homeostasis)Cardiovascular disease (implicated through apoptosis/autophagy balance, though context is cell type-specific)Other (potential diagnostic biomarker in several diseases, e.g., renal cell carcinoma, gastric cancer, colorectal cancer)
05

Safety considerations

Off-target gene silencing due to imperfect binding specificity.Therapeutic manipulation may alter cell survival and apoptosis, potentially promoting tumor growth or impairing tissue regeneration depending on dose and disease context.Risk of affecting essential processes, including autophagy and apoptosis, leading to unintended muscle wasting or enhanced tumorigenesis.
06

Interacting drugs

miRNA mimics (experimental)

2 more in the full profile.

07

Biomarkers

Aberrant levels of MIR378B in blood or tumor tissue are biomarkers for patient selection and prognosis in renal cell carcinoma, colorectal cancer, glioma, cervical cancer, and potentially other tumors

Beyond the preview

Go deeper on MicroRNA 378b (MIR378B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 378b (MIR378B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call